ArticleJournal of medicinal chemistry2012

Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.

Xingyu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.